InvaGen Pharmaceuticals Plans to Open New Islip, NY, Facility & Create 400 Jobs
01/27/2012
Located in Long Island, NY, InvaGen is a fast-growing generic pharmaceutical company. About 330 workers are employed at its drug product development and commercial operations at three different Hauppauge, NY, facilities.
Construction activity (dependent upon obtaining building permits) could begin as early as February, and will transform one building into a manufacturing, research lab and packaging operation. The firm will invest $20 million in the purchase and renovation part of the project, and $19 million more later in new equipment and research.
Plans call for the revamped facility to be fully operational in five years. The firm anticipates hiring 150 employees within the first two years and paying them an average wage of around $50,000 (according to documents it filed with the Islip Industrial Development Agency).
InvaGen will receive almost $2 million in tax credits through the state's jobs program after meeting job-creation goals, and $3.8 million in tax exemptions over 12 years.
Project Announcements
Barnwell Tissue Solutions Plans Barnwell, South Carolina, Operations
06/23/2025
Swiss-Based Temenos Plans Orlando, Florida, Operations
06/23/2025
Phoenix Manufacturing Expands Glasgow, Missouri, Operations
06/23/2025
Otto Aviation Plans Jacksonville, Florida, Manufacturing Operations
06/20/2025
AMI Metals Expands Spokane, Washington, Production Operations
06/20/2025
Newly Weds Foods Plans Dyersburg, Tennessee, Production Operations
06/20/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
The New Math Behind Mexico and U.S. Manufacturing Decisions
Q2 2025